Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 1
1968 6
1969 3
1970 8
1971 2
1972 6
1973 6
1974 11
1975 9
1976 11
1977 9
1978 17
1979 14
1980 15
1981 10
1982 18
1983 27
1984 22
1985 25
1986 21
1987 24
1988 23
1989 23
1990 33
1991 23
1992 17
1993 17
1994 21
1995 16
1996 21
1997 20
1998 20
1999 15
2000 27
2001 25
2002 38
2003 20
2004 18
2005 31
2006 27
2007 26
2008 32
2009 23
2010 38
2011 46
2012 58
2013 108
2014 106
2015 127
2016 93
2017 100
2018 107
2019 129
2020 115
2021 79
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

1,710 results

Results by year

Filters applied: . Clear all
Page 1
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial.
Harding C, Mossop H, Homer T, Chadwick T, King W, Carnell S, Lecouturier J, Abouhajar A, Vale L, Watson G, Forbes R, Currer S, Pickard R, Eardley I, Pearce I, Thiruchelvam N, Guerrero K, Walton K, Hussain Z, Lazarowicz H, Ali A. Harding C, et al. BMJ. 2022 Mar 9;376:e068229. doi: 10.1136/bmj-2021-0068229. BMJ. 2022. PMID: 35264408 Free PMC article. Clinical Trial.
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Wang M, Rule S, Zinzani PL, Goy A, Casasnovas O, Smith SD, Damaj G, Doorduijn J, Lamy T, Morschhauser F, Panizo C, Shah B, Davies A, Eek R, Dupuis J, Jacobsen E, Kater AP, Le Gouill S, Oberic L, Robak T, Covey T, Dua R, Hamdy A, Huang X, Izumi R, Patel P, Rothbaum W, Slatter JG, Jurczak W. Wang M, et al. Lancet. 2018 Feb 17;391(10121):659-667. doi: 10.1016/S0140-6736(17)33108-2. Epub 2017 Dec 11. Lancet. 2018. PMID: 29241979 Free PMC article. Clinical Trial.
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study.
Gounder M, Schöffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, Attia S, Chugh R, Chen TW, Jahan T, Loggers ET, Gupta A, Italiano A, Demetri GD, Ratan R, Davis LE, Mir O, Dileo P, Van Tine BA, Pressey JG, Lingaraj T, Rajarethinam A, Sierra L, Agarwal S, Stacchiotti S. Gounder M, et al. Lancet Oncol. 2020 Nov;21(11):1423-1432. doi: 10.1016/S1470-2045(20)30451-4. Epub 2020 Oct 6. Lancet Oncol. 2020. PMID: 33035459 Clinical Trial.
Insect repellents.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Aug 26;61(1579):129-132. Med Lett Drugs Ther. 2019. PMID: 31593398 Review. No abstract available.
Amisulpride.
[No authors listed] [No authors listed] Am J Health Syst Pharm. 2020 Nov 16;77(23):1917-1918. doi: 10.1093/ajhp/zxaa292. Am J Health Syst Pharm. 2020. PMID: 33196816 No abstract available.
Revefenacin (Yupelri) for COPD.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Jan 28;61(1564):14-15. Med Lett Drugs Ther. 2019. PMID: 30856160 Review. No abstract available.
Entinostat for the treatment of breast cancer.
Trapani D, Esposito A, Criscitiello C, Mazzarella L, Locatelli M, Minchella I, Minucci S, Curigliano G. Trapani D, et al. Expert Opin Investig Drugs. 2017 Aug;26(8):965-971. doi: 10.1080/13543784.2017.1353077. Epub 2017 Jul 24. Expert Opin Investig Drugs. 2017. PMID: 28718331 Free article. Review.
1,710 results